Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:15 PM
Ignite Modification Date:
2025-12-24 @ 9:15 PM
NCT ID:
NCT02528604
Eligibility Criteria:
Inclusion Criteria:
* Patients with symptomatic persistent atrial fibrillation of less than 1-year duration.
* Patients must be over 65 years old.
* Patients give informed consent prior to participating in this study.
Exclusion Criteria:
* Paroxysmal atrial fibrillation.
* Long-standing persistent or permanent atrial fibrillation.
* Previous pacemaker implantation.
* Previous atrial ablation.
* Patient is unable to take warfarin or other oral anti-coagulant medication.
* Patient is suffering with unstable angina in last one week.
* Patient has had a myocardial infarction within last two months.
* Patient is expecting or has had major cardiac surgery within last two months.
* Patient is participating in a conflicting study.
* Patient is unable to perform exercise testing.
* Patient is mentally incapacitated and cannot consent or comply with follow-up.
* Patient has New York Heart Association (NYHA) class III/IV heart failure.
* Patient has left ventricular ejection fraction (LVEF) less than 35% not secondary to tachycardia.
* Pregnancy.
* Patient suffers with other cardiac rhythm disorders.
* Recent coronary artery intervention or other factors suggesting clinical instability (ECG, clinical or laboratory findings).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02528604
Study Brief:
Protocol Section:
NCT02528604